Glen Harbor Capital Management’s aTyr Pharma ATYR Stock Holding History

Glen Harbor Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$38K	Sell	10,914 -32	-0.3%	-$118	﹤0.01%	1249
2019 Q2	$56K	Hold	10,946	–	–	﹤0.01%	1238
2019 Q1	$84K	Hold	10,946	–	–	﹤0.01%	1179
2018 Q4	$76K	Hold	10,946	–	–	﹤0.01%	1154
2018 Q3	$125K	Hold	10,946	–	–	﹤0.01%	1162
2018 Q2	$140K	Hold	10,946	–	–	﹤0.01%	1080
2018 Q1	$406K	Hold	10,946	–	–	0.01%	712
2017 Q4	$536K	Hold	10,946	–	–	0.01%	622
2017 Q3	$774K	Hold	10,946	–	–	0.02%	463
2017 Q2	$529K	Hold	10,946	–	–	0.01%	579
2017 Q1	$536K	Sell	10,946 -1,891	-15%	-$86.4K	0.01%	538
2016 Q4	$386K	Buy	+12,837	New	+$527K	0.01%	565

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCIM

Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Glen Harbor Capital Management's ATYR Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its aTyr Pharma (ATYR) stake by 0.29% in Q3 2019, selling an estimated $118 and leaving 10,914 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Glen Harbor Capital Management first reported a position in ATYR in Q4 2016 and has held it in 12 quarters since. The position peaked at $774K in Q3 2017. 19 funds tracked by Wall St. Rank hold ATYR as of Q3 2019.

Glen Harbor Capital Management held 10,914 shares of aTyr Pharma worth $38K as of Q3 2019.
Glen Harbor Capital Management sold 32 aTyr Pharma shares in Q3 2019, an estimated $118.
aTyr Pharma made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1249 holding.
Glen Harbor Capital Management first reported a position in aTyr Pharma in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's aTyr Pharma position peaked at $774K in Q3 2017.
19 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.